Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs

Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs

(2014) John W. McCall et al.   VETERINARY PARASITOLOGY

Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States

(2012) Dwight D Bowman   Parasites & Vectors

Moxidectin and the avermectins: Consanguinity but not identity

(2012) Roger Prichard et al.   International Journal for Parasitology-Drugs and Drug Resistance

Progress and challenges in the discovery of macrofilaricidal drugs

(2011) Timothy G Geary et al.   Expert Review of Anti-Infective Therapy

Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Dirofilaria immitis

(2011) B.L. Blagburn et al.   VETERINARY PARASITOLOGY

Heartworm Biology, Treatment, and Control

(2009) Dwight D. Bowman et al.   VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE